an episode of inability to breathe; cardiomyopathy; pulmonary edema; lose feeling in my lower extremities; My hips begin to hurt; both legs go numb; unable to walk for more than 200 feet; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73-year-old male patient received BNT162b2 (BNT162B2), on 24Feb2021 at 08:15 as dose 2, single (Lot number: EN6201) at the age of 73 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "High blood pressure" (unspecified if ongoing); "high cholestrol" (unspecified if ongoing); "atherosclorsis" (unspecified if ongoing); "Penicillin Allergy" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: pfizer (Dose Number: 1, Batch/Lot No: EN5318, Location of injection: Arm Left, Vaccine Administration Time: 08:00 AM), administration date: 03Feb2021, for Covid-19 Immunization. Patient did not receive any other vaccines within 4 weeks prior and received unspecified other medications 2 weeks prior to the COVID vaccine. The patient was not tested positive for covid 19 prior to vaccination and tested post vaccination. The following information was reported: ARTHRALGIA (disability) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "My hips begin to hurt"; DYSPNOEA (hospitalization, disability, life threatening) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "an episode of inability to breathe"; HYPOAESTHESIA (disability) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "both legs go numb"; CARDIOMYOPATHY (hospitalization, disability, medically significant, life threatening) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae"; PARAESTHESIA (disability) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "lose feeling in my lower extremities"; PULMONARY OEDEMA (hospitalization, disability, medically significant, life threatening) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "pulmonary edema"; GAIT DISTURBANCE (disability) with onset 28Oct2021 at 11:00, outcome "recovered with sequelae", described as "unable to walk for more than 200 feet". The patient was hospitalized for dyspnoea, cardiomyopathy, pulmonary oedema (hospitalization duration: 5 day(s)). The events "an episode of inability to breathe", "cardiomyopathy", "pulmonary edema", "lose feeling in my lower extremities", "my hips begin to hurt", "both legs go numb" and "unable to walk for more than 200 feet" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: Computerised tomogram: (unspecified date) Unknown results; Neurological tests: (unspecified date) Unknown results; Magnetic resonance imaging: (unspecified date) Unknown results; SARS-CoV-2 test: (28Oct2021) Negative, notes: Nasal Swab. Therapeutic measures were taken as a result of dyspnoea, cardiomyopathy, pulmonary oedema, paraesthesia, arthralgia, hypoaesthesia, gait disturbance.  Clinical course: No other vaccine on same date. It was reported that, approximately 2 months after the second dose, he began to lose feeling in his lower extremities. His hips begin to hurt and then both legs go numb. This started in April, 2021. This problem continues to present with no explanation after numerous MRIs, cat scans and neurological tests. He was unable to walk for more than 200 feet without legs going numb. In October he experienced an episode of inability to breathe. After a week in the hospital, he was diagnosed with pulmonary edema and cardiomyopathy. This occurred in October2021. Ae resulted in: [Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage]. Ae treatment: Various from cat scans to MRI's to medications.